Lambert-eaton myasthenic syndrome.
Curr Treat Options Neurol
; 11(2): 77-84, 2009 Mar.
Article
en En
| MEDLINE
| ID: mdl-19210909
ABSTRACT
Lambert Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disease. Often, the signs and symptoms of LEMS are mistaken for myasthenia gravis and therefore the workup is misdirected. A physician must look for an occult malignancy when the diagnosis is made and then continue to search for a malignancy for at least 5 years after diagnosis. The diagnosis of LEMS can be confirmed with electrophysiologic studies or with serum calcium channel antibodies. In most patients with LEMS, 3,4-diaminopyridine will improve strength. In patients without malignancy, immunosuppressants do have a role in the treatment of LEMS. Patients and physicians must be aware that certain situations and drugs may exacerbate weakness.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Curr Treat Options Neurol
Año:
2009
Tipo del documento:
Article
País de afiliación:
Estados Unidos